Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Visionary Research on Detecting Cancer Cells Early Receives NIH funding
Uncategorized

Visionary Research on Detecting Cancer Cells Early Receives NIH funding

By medwebSep 28, 2012
Share
Facebook Twitter Email

Two Northwestern University faculty members have received a prestigious 2012 NIH Director’s Transformative Research Award from the National Institutes of Health (NIH) to develop technology to detect cancer metastasis at its earliest stages, allowing for life-preserving interventions.

The NIH this month awarded approximately $155 million to 81 researchers across the country through its High Risk-High Reward program. The program funds visionary research that exhibits the potential to transform scientific fields and speed the translation of research into improved health.

Lonnie D. Shea and Vadim Backman, both of the McCormick School of Engineering and Applied Science, will receive $4.2 million over five years for their innovative project. The grant is one of only 20 Transformative Research Awards given nationwide by NIH.

Their research team includes three others whose expertise also is critical in addressing such a complex problem. They are Jacqueline S. Jeruss, MD, PhD, assistant professor of surgery and a breast cancer specialist, and Stephen D. Miller, PhD, the Judy Gugenheim Research Professor in Microbiology-Immunology, both at the Feinberg School of Medicine; and Andrew Mazar, director of the Center for Developmental Therapeutics in the Chemistry of Life Processes Institute.

Cancer is the second-leading cause of death worldwide, with most cancer-related deaths resulting from metastasis of cells from the primary tumor. With the NIH support, Shea and Backman will work to develop an implant material that creates a localized biological environment that will attract metastatic cancer cells and a sensor that indicates when cells have colonized the implant. The sensor also will monitor cell growth.

Shea’s role is to adapt techniques from his tissue engineering research to develop the biomaterial implant, and Backman’s contribution centers on applying his non-invasive imaging technologies to act as the sensor.  

Shea is a professor of chemical and biological engineering, and Backman is a professor of biomedical engineering and the Walter Dill Scott Professor. They are co-principal investigators on the grant.

Shea and Backman are members of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Chemistry of Life Processes Institute. Shea also is member of the Institute for BioNanotechnology in Medicine (IBNAM).

The High Risk-High Reward program awards are divided into three categories: the NIH Director’s Transformative Research Award, Pioneer and New Innovator awards.

The Transformative Research Award program, established in 2009, promotes cross-cutting, interdisciplinary approaches and is open to individuals and teams of investigators who propose research that has the potential to create or overturn fundamental paradigms.

Research
Share. Facebook Twitter Email

Related Posts

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.